|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Amy K. Reeve , Eve M. Simcox , Michael R. Duchen , Doug M. TurnbullPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: Softcover reprint of the original 2nd ed. 2016 Weight: 6.626kg ISBN: 9783319803944ISBN 10: 3319803948 Pages: 380 Publication Date: 31 May 2018 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Language: English Table of ContentsPart I. Mitochondria and Neurodegenerative Disease.- An Introduction to Mitochondria, Their Structure and Functions.- Part II. Mitochondrial Dysfunction: Causes and Effects?.- Neurodegeneration in Mitochondrial Disorders.- The Ageing Brain, Mitochondria and Neurodegeneration.- Mitochondrial Genes and Neurodegenerative Disease.- Mitochondrial Signalling and Neurodegeneration.- Part III. Functional Consequences of Mitochondrial Dysfunction.- Life on the Edge: Determinants of Selective Neuronal Vulnerability in Parkinson’s Disease.- Mitochondrial Dynamics and Neurodegeneration.- Mitochondrial Dysfunction and Transport in Demyelinating Disease with Inflammation.- Mitochondria, the Synapse, and Neurodegeneration.- Protein Misfolding and Aggregation: Implications for Mitochondrial Dysfunction and Neurodegeneration.- Mitochondrial Degradation, Autophagy and Neurodegenerative Disease.- The Deleterious Duo of Neurodegeneration: Lysosomes and Mitochondria.- PartIV. Measuring the Contribution of Mitochondrial Dysfunction to Neurodegenerative Disease.- Can We Accurately Model Mitochondrial Dysfunction in Neurodegeneration?.- Mitochondrial Function and Dynamics Imaged In Vivo.- Part V. The Future.- Development of Treatments and Therapies to Target Mitochondrial Dysfunction.- Summary and Conclusions.ReviewsAuthor InformationAmy K. Reeve Amy did her undergraduate degree in Neuroscience at Edinburgh University before moving to the Mitochondrial Research Group at Newcastle University for her PhD studies. She completed her PhD in the study of the molecular mechanisms of neurodegenerative disease in 2007 and now has her own research group within the Wellcome Trust Centre for Mitochondrial Research. Her current research interests centre around understanding the mechanisms behind the neurodegeneration seen in Parkinson’s disease, and the contribution of mitochondrial dysfunction to these changes. Funded by Parkinson’s UK as a research fellow Amy’s interests lie in understanding how changes within mitochondria, mitochondrial transport and the interaction of mitochondrial with alpha-synuclein contributes to the development of Parkinson’s disease. Eve M. Simcox Eve did her undergraduate degree in Biomedical Science at Newcastle University and continued her studies within the Mitochondrial Research Group for her PhD. She completed her PhD in the study of the turnover and dynamics of mitochondria in neurodegenerative disease in 2014 and now works as the impact officer for the faculty of Science, Agriculture and Engineering. Michael R. Duchen Michael obtained his Bachelor of Medicine degree from Oxford and London Universities, and moved to UCL for his PhD studies. He has remained at UCL since, where he is now a Professor of Physiology. Michael founded and leads the UCL consortium for Mitochondrial Research and leads a successful research group. Michael's interests lie primarily in understanding the relationships between mitochondrial biology and cell signalling. His research group's main interest lies in understanding the inter-relationship between calcium signalling, mitochondria and free radical biology in cell physiology and pathophysiology. Particular contributions have been made into understanding the contribution of mitochondrial dysfunction to cell injury and death. Doug M. Turnbull Professor Turnbull is a clinical academic who leads a basic science research programme in conjunction with developing clinical services. He has three main roles. Director of the Wellcome Trust Centre for Mitochondrial Research. The Wellcome Trust Centre is focused on research to improve the lives of patients with mitochondrial disease. This includes research to identify the genetic defect in patients with mitochondrial disease and his work also focuses understanding the molecular mechanisms underlying the neurological features in patients. With colleagues he is searching for new therapies for patients and actively involved in clinical studies evaluating potential therapies. He has been actively involved in work to prevent the transmission of mitochondrial DNA disease using an IVF technique called mitochondrial donation. Lead for the NHS Highly Specialised Services for Rare Mitochondrial Services for Adults and Children. Professor Turnbull developed this service provides optimum care for patients with mitochondrial disease throughout the UK with Centres in Newcastle, London and Oxford. This service was built on the back of clinical and basic research and the service reviews in excess of 800 patients per year. The service has developed care pathways and patient guidance that are used worldwide of the benefit of patients. Director MRC/BBSRC Centre for Ageing and Vitality. Professor Turnbull has a major interest in understanding the basic mechanisms involved in human ageing with particular emphasis on the role of mitochondria. The MRC Centre is focused on understanding how these mechanisms are influenced by lifestyle interventions and studies aimed at promoting healthy ageing. Tab Content 6Author Website:Countries AvailableAll regions |